Heartflow Inc 's Comment on Competition and Industry Peers
The company competes with large multinational commercial organizations that have substantial resources and distribution capabilities in the non-invasive market. It also faces competition from companies developing AI-based platforms utilizing coronary computed tomography angiography (CCTA) to diagnose coronary artery disease (CAD), including Cleerly, Inc., Elucid Bioimaging Inc., and Keya Medical Technology Co., Ltd. Additional competition may arise from companies developing AI-based platforms not currently focused on the CAD market. Key competitive factors include the accuracy, reliability, and clinical utility of the test; speed and efficiency of diagnosis; per-patient economics such as reimbursement and costs; availability and ease of use, including integration with hospital systems and customer support; and marketing and physician education efforts that influence physician awareness and practice patterns.
September 22, 2025
AI in Healthcare: HeartFlow s FDA Approval and Cigna Coverage Marks a Milestone in Cardiac Care By In a significant development for the healthcare industry, HeartFlow, a leader in AI-enhanced cardiovascular technology, has recently obtained FDA 510(k) clearance and subsequently launched its next-generation HeartFlow Plaque Analysis platform. This AI-powered system promises to revolutionize the assessment and management of coronary artery disease, reflecting the growing trend of integrating artificial intelligence into medical diagnostics. Notably, Cigna Health Plans, one of the largest health insurance providers in the United States, has announced that it will provide coverage for this cutting-edge technol...
Sources:
Heartflow Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Heartflow Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
